Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for central neuropathic pain in multiple sclerosis
2005-005265-11Phase 3Completed
- Sponsor
- GW Pharmaceuticals
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing Sativex add-on with Placebo add-on (2 arms). Started Feb 2006; status: completed.
02
Drugs
cannabidiol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2005-005265-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005265-11.